CommercialCoverageMedium impact
07.00.05j, In Vivo Allergy Sensitivity Testing
Independence Blue Cross·Allergy & Immunology, Family Medicine, Internal Medicine +1 more·Medical Policy
Effective date
Sep 8, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross updated their medical necessity criteria for In Vivo Allergy Sensitivity Testing (policy 07.00.05j). This affects commercial plan coverage requirements and billing guidelines for allergy testing procedures.
Action Required
By September 8, 2025: Billing team must review updated medical necessity criteria for In Vivo Allergy Sensitivity Testing procedures. Update prior authorization protocols and documentation requirements for allergy testing claims submitted to Independence Blue Cross commercial plans. Ensure providers understand new criteria to avoid claim denials.